A method for treating at least one disease or condition selected from the group consisting of inflammatory bowel disease, rheumatoid arthritis, Crohn's disease, ulcerative colitis, inflammatory renal pathology, glomerulonephritis, and nephritis, said method comprising administering to a person in need thereof an effective amount of a compound of formula (I):
- wherein:
- A is —X1— or —X1—OC(R9)(R10)—, in which
- X1 is an alkyl group having from 1 to 5 carbon atoms, optionally substituted with one or more alkyl groups having from 1 to 5 carbon atoms or one or more alkoxy groups having from 1 to 3 carbon atoms, and
- R9 and R10, which may be identical or different to each other, are each hydrogen, an alkyl group having from 1 to 5 carbon atoms or an alkoxy group having from 1 to 3 carbon atoms,
- Y is N(R11)(R12), N(R13)O(R14), N(R13)N(R14)(R15), N(R13)—X2—N(R14)(R15), or N(R13)—X2—CO—X3, wherein
- R11 is hydrogen, an alkyl group having from 1 to 5 carbon atoms, an alkoxy group having from 1 to 3 carbon atoms, or R11 together with R12 forms a 4- to 7-membered heterocycle,
- R12 is hydrogen, an alkyl group having from 1 to 5 carbon atoms, an alkoxy group having from 1 to 3 carbon atoms, an aryl group, a heteroaryl group, an alkylaryl group, an alkylheteroaryl group, COR′, COOR′, or CON(R′)(R″) wherein R′ and R″, which may be identical or different to each other, each represent hydrogen or an alkyl group having from 1 to 5 carbon atoms, or R12 together with R11, forms a 4- to 7-membered heterocycle,
- R13 and R15, which may be identical or different to each other, are each hydrogen, an alkyl group having from 1 to 5 carbon atoms or an alkoxy group having from 1 to 3 carbon atoms,
- R14 is hydrogen, an alkyl group having from 1 to 5 carbon atoms, an aryl group, a heteroaryl group, an alkylaryl group, an alkylheteroaryl group, COR′, COOR′, or CON(R′)(R″) wherein R′ and R″, which may be identical or different to each other, each represent hydrogen or an alkyl group having from 1 to 5 carbon atoms,
- X2 is an alkyl group having from 1 to 5 carbon atoms, optionally substituted with one or more alkyl groups having from 1 to 5 carbon atoms or one or more alkoxy groups having from 1 to 3 carbon atoms,
- X3 is OH, NH2, NHOH or NHNH2,
- R1 and R2, which may be identical or different to each other, are each hydrogen, an alkyl group having from 1 to 5 carbon atoms or an alkoxy group having from 1 to 3 carbon atoms,
- R3, R4 and R8, which may be identical or different to each other, are each hydrogen, an alkyl group having from 1 to 5 carbon atoms, an alkoxy group having from 1 to 3 carbon atoms, a halogen atom, —OH, —N(R′)(R″), —N(R′)COR″, —CN, —CONR′R″, —SO2NR′R″, —SO2R′, nitro or trifluoromethyl;
- wherein R′ and R″, which may be identical or different to each other, each represent hydrogen or an alkyl group having from 1 to 5 carbon atoms,
- R5 is hydrogen, an alkyl group having from 1 to 5 carbon atoms, an alkoxy group having from 1 to 3 carbon atoms, a halogen atom, —OH, —N(R′)(R″), —N(R′)COR″, nitro or trifluoromethyl, or R5 together with one of R6 and R7 forms a ring having 5 or 6 carbon atoms;
- wherein R′ and R″, which may be identical or different to each other, each represent hydrogen or an alkyl group having from 1 to 5 carbon atoms,
- R6 and R7, which may be identical or different to each other, are each hydrogen, an alkyl group having from 1 to 5 carbon atoms, or together form a group C═O, or one of R6 and R7, together with R5, forms a ring having 5 or 6 carbon atoms;
- or a pharmaceutically acceptable salt thereof.